Macular Thickening Following Phacoemulsification Surgery in Diabetic Patients.
Conditions
Interventions
Intervention 1: Control group: Administering Tearlose artificial tear drops (Sinadarou, Tehran, Iran) every 8 hours, from one day before to 4 weeks after Phaco surgery. Intervention 2: Intervention gr
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with controlled diabetes (fasting blood sugar [FBS] = 126 mg/dL and hemoglobin A1c [HbA1c] < 7). Patients scheduled for cataract surgery using the phacoemulsification technique.
Exclusion criteria
Exclusion criteria: Complicated phacoemulsification surgery history of glaucoma uveitis prior ocular surgeries intravitreal drug injection within the past 3 months retinal photocoagulation laser treatment within the past 6 months presence of proliferative diabetic retinopathy (PDR) macular edema (central macular thickness [CMT] > 320 microns) any pre-existing macular disease media opacity interfering with macular OCT imaging
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Central macular thickness (CMT). Timepoint: Preoperatively, as well as at 1 week, 4 weeks, and 12 weeks postoperatively. Method of measurement: Macular thickness will be measured using SD-OCT (Heidelberg Engineering OCT Spectralis, USA). | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual acuity. Timepoint: Preoperatively, as well as at 1 day, 1 week, 4 weeks, and 12 weeks postoperatively. Method of measurement: E-chart.;Intraocular pressure. Timepoint: Preoperatively, as well as at 1 day, 1 week, 4 weeks, and 12 weeks postoperatively. Method of measurement: Goldmann tonometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Ansari
Ahvaz University of Medical Sciences
Outcome results
None listed